Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.

Abstract : As conflicting results have been observed by some authors in liver recipients, the aim of the study was to evaluate lamivudine therapy in 3 groups of patients with chronic hepatitis B: non-transplanted patients, liver and kidney recipients.
Complete list of metadatas

https://hal.univ-lorraine.fr/hal-02014614
Contributor : Evelyne Schvoerer <>
Submitted on : Monday, February 11, 2019 - 4:29:45 PM
Last modification on : Friday, March 8, 2019 - 3:06:04 PM

Identifiers

  • HAL Id : hal-02014614, version 1
  • PUBMED : 11938042

Collections

Citation

Evelyne Schvoerer, Imed Kabissa, Emmanuelle Cotto, Anne-Christine Jouvencel, Charles Balabaud, et al.. Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, Elsevier Masson, 2002, 26 (1), pp.62-6. ⟨hal-02014614⟩

Share

Metrics

Record views

15